Bianca Harris, MD, MSc

Pulmonologist & Critical Care Medicine Specialist

Pictured: Bianca Harris

About Me

I am a specialist in pulmonary and critical care medicine with an interest in lung diseases that result from immune-suppressing cancer treatments. My research focuses on how the microorganisms that normally inhabit the body contribute to infectious diseases and other respiratory complications following hematopoietic stem cell transplantation.

Read more
  • Clinical Expertise: Pulmonary Disease in the Immunocompromised Patient; Pulmonary Complications of Hematopoietic Stem Cell Transplantation
  • Languages Spoken: English
  • Education: MD, New York University School of Medicine; MSc, London School of Hygiene and Tropical Medicine (UK)
  • Residencies: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Fellowships: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Board Certifications: Internal Medicine; Pulmonary Disease; Critical Care Medicine

My Research

View my lab

See Bianca Harris’ laboratory
research at Memorial Sloan Kettering.

See My Colleagues


Diagnostic bronchoscopy in solid-organ and hematopoietic stem cell transplantation, Harris B, Lowy FD, Stover DE, Arcasoy SM.  Annals of the American Thoracic Society, 2013-10(1):39-49.

The association of systemic microvascular changes with lung function and lung density: a cross-sectional study. Harris B, Ahmed F, Klein R, Jerosch-Herold M, Hoffman EA, Jacobs D, Klein B, Wong T, Cotch MF, Barr RG. PLoS ONE 2012:7(12): doi:10.1371/journal.pone.0050224.

Ventricular assist device-related infections, Gordon RJ, Quagliarello (Harris) B, Lowy FD, Lancet Infectious Diseases 2006: 6(7); 426-37.

Staphylococcus aureus colonization and the risk of infection in critically Ill patients. Keene A, Vavagiakis P, Lee MH, Finnerty KA, Nicholls D, Cespedes C, Quagliarello (Harris) B, Chiasson MA, Chong DH, Lowy FD. Infection Control and Hospital Epidemiology 2005: 26 (7): 622-627.

Read more

Molecular epidemiologic analysis of two Staphylococcus aureus clonal types colonizing AIDS patients. Gordon R, Quagliarello (Harris) B, Cespedes C, Chung C, de Lencastre H, Vavagiakis P, Miller M, Zeller B, and Lowy FD. A Clinical Infectious Diseases 2005: 40 (7): 1028-36.

Strains of Staphylococcus aureus obtained from drug-use networks are closely linked. Quagliarello (Harris) B, Cespedes C, Miller M, Toro A, Vavagiakis, Klein RS, Lowy FD. Clinical Infectious Diseases 2002: 35; 671-677.

Factors associated with carriage of penicillin-resistant Streptococcus pneumoniae among Vietnamese children: a rural-urban divide. Quagliarello (Harris) B, Parry CM, Hien TT, Farrar J. Journal of Health, Population and Nutrition 2003 Dec; 21 (4): 316-24.

Differences between Staphylococcus aureus isolates from medical and nonmedical hospital personnel. Cespedes C, Miller M, Quagliarello (Harris) B, Vavagiakis P, Klein RS, Lowy FD. Journal of Clinical Microbiology 2002: 40 (7); 2594-2597.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more